Medication Safety Risks Rise as Older Australians Enter Residential Aged Care
A large Australian study is putting fresh attention on a familiar but often underrecognized clinical problem: the prescribing cascade. Researchers found that this pattern became more common after older adults moved into long-term residential aged care, suggesting that one of the most medically fragile transitions in later life can also be one of the riskiest for medication-related harm.
The research, led by the Registry of Senior Australians Research Centre at the South Australian Health and Medical Research Institute and Flinders University, analyzed medication records for more than 167,000 people aged 65 and older who entered long-term care facilities across Australia. According to the study, 16.7% of residents experienced at least one prescribing cascade before entering care. After admission, that figure rose to 25.1%.
Those numbers matter because prescribing cascades can quietly intensify medicine burden. A side effect from one drug may be mistaken for a new medical condition, which can lead to a second drug being added. Over time, that can trigger still more side effects, more treatment decisions, and more risk. In older adults, especially those already managing multiple chronic conditions, the consequences can become difficult to untangle.
What a Prescribing Cascade Means in Practice
The concept is straightforward, but the real-world effects can be serious. When a patient develops a symptom after starting a medicine, the safest response may be to ask whether the original drug is responsible. In a prescribing cascade, that question is missed or deferred, and the new symptom is treated as a separate illness. Instead of simplifying the regimen, the care pathway becomes more complex.
That complexity is especially relevant in residential aged care, where residents often arrive with long medication lists, changing health needs, and higher frailty. A transition into care can involve reassessment, medication changes, and close observation of new or worsening symptoms. The study suggests that this environment may also create conditions where treatment decisions accumulate quickly.
The researchers identified many cascades involving medicines that are commonly used in older populations. Many were linked to drug classes already recognized as high risk for older adults, including antipsychotics, benzodiazepines, and opioids. Those medicines can be clinically appropriate in some circumstances, but they also carry well-established concerns around sedation, falls, confusion, dependence, and other harms in older patients.
A Vulnerable Point in the Care Journey
Lead researcher Professor Gill Caughey said the transition into residential aged care is one of the most vulnerable periods for medication safety. The study’s results support that view by showing that prescribing cascades were more likely to occur after entry into care, rather than before it.
That timing is important. Admission to residential aged care is not just a change of address. It can coincide with declining health, a loss of independence, closer supervision, and new treatment decisions made under pressure. Some residents may be dealing with worsening cognition, pain, agitation, insomnia, or mobility issues. In that setting, side effects can be hard to distinguish from underlying disease progression.
The study does not claim that every cascade reflects inappropriate care. The source text makes clear that some instances may be appropriate. But the researchers also found that many cascades involved medications considered inappropriate for older people under international guidelines. That finding raises the possibility that at least some medication-related harm could be reduced through more systematic review at the point of care transition.
Why This Matters Beyond Australia
Although the data come from Australia, the underlying issue is broader. Health systems in many countries are managing older populations with increasing levels of multimorbidity, polypharmacy, and long-term care demand. Residential care admissions often happen after hospitalizations, functional decline, or caregiver strain, all of which increase the chance of medication regimens changing rapidly.
What makes prescribing cascades difficult is that they can look reasonable in the moment. Each decision may have a clinical rationale. A new symptom appears. A clinician responds. Another symptom follows. Without deliberate review of the full sequence, the overall pattern can be missed. For older adults, that can mean more medicines, more adverse effects, and more difficulty identifying which treatment is helping and which may be causing harm.
The scale of this study gives the issue added weight. With more than 167,000 people included, the findings suggest the problem is not isolated to a small subgroup or a single institution. Instead, it points to a system-level medication safety challenge centered on a predictable life transition.
What the Findings Suggest for Care Teams
The strongest implication is not that medicines should be avoided outright, but that prescribing during aged care entry may need more scrutiny. Medication reconciliation, deprescribing review, and explicit checks for side effects may all be relevant tools. For care teams, the key question is whether a new symptom represents a new illness or a reaction to a current treatment.
That distinction can shape outcomes. A resident who is experiencing a drug-related effect may not benefit from another prescription layered on top. They may benefit more from revisiting the original decision, adjusting the dose, stopping a medicine, or choosing a safer alternative. In a population already vulnerable to medication burden, those choices can have outsized effects.
The study also reinforces a broader principle in geriatric care: transitions deserve heightened attention. Whether a person is moving from home to residential care, from hospital back to the community, or between specialist and primary care settings, medication regimens are often in flux. These are moments when harm can be introduced, but they are also moments when it can be prevented.
A Clear Signal for Medication Review
The findings from the Australian team do not solve the problem on their own, but they provide a clear signal about where to look. Prescribing cascades were already present before admission for a notable share of residents. After entry into residential aged care, they became even more common. That pattern suggests the transition itself should be treated as a medication safety checkpoint.
As populations age and demand for long-term care rises, the question is likely to become more urgent. The study frames the issue in practical terms: older adults entering residential care are exposed to prescribing patterns that may unintentionally increase harm. For providers, policymakers, and families, that makes one conclusion hard to ignore. The move into aged care is not only a social and clinical transition. It is also a critical moment to ask whether every medicine on the chart is still helping more than it harms.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
